Document Detail

High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
MedLine Citation:
PMID:  21359408     Owner:  NLM     Status:  Publisher    
Percutaneous coronary intervention (PCI) represents the most important treatment of coronary artery stenosis today. But instent restenosis (ISR) is a limitation for the outcome. Fas and Fas Ligand have been implicated in apoptosis and vessel wall inflammation. Their role in ISR is not known so far. In this prospective study we studied 137 patients with stable coronary artery disease who underwent elective PCI. Blood samples were taken directly before and 24 hours after PCI. Soluble (s)Fas and sFas Ligand serum levels were measured by ELISA. Restenosis was evaluated six to eight months later either by coronary angiography or by exercise testing. During the follow-up period, 18 patients (13%) developed ISR. At baseline, patients with ISR had significantly lower median sFas, as well as sFas Ligand levels compared to patients without ISR (sFAS: ISR 492 pg/ml, no ISR 967 pg/ml, p=0.014; sFAS Ligand: ISR: 26 pg/ml, no ISR: 42 pg/ml, p=0.001). After PCI median sFas levels significantly decreased in patients with ISR compared to patients without ISR [ISR: -152 pg/ml (IQR -36 to -227), no ISR: -38 pg/ml (IQR -173 to +150 pg/ml), p=0.03]. sFas Ligand levels after PCI significantly increased in ISR patients compared to patients without ISR [ISR: 14 pg/ml (IQR -3 to +26 pg/ml), no ISR -6 pg/ml (IQR -22 to +21 pg/ml), p=0.014]. In conclusion, sFas and sFas Ligand seem to be associated with the development of ISR. Determination of serum levels before and after PCI might help identifying patients at higher risk of ISR.
K M Katsaros; F Wiesbauer; W S Speidl; S P Kastl; K Huber; G Zorn; A Niessner; D Glogar; G Maurer; J Wojta
Related Documents :
19937048 - Significance of aortic atherosclerotic disease in possibly embolic stroke: 64-multidete...
1797928 - Natural history of chronic bilateral internal carotid artery occlusion.
15274118 - Apoc-i and apoc-iii as potential plasmatic markers to distinguish between ischemic and ...
20065248 - Early clinical worsening in patients with tia or minor stroke: the austrian stroke unit...
17400678 - Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic func...
15671388 - Clinicians' response to radiologists' reports of isolated subsegmental pulmonary emboli...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-28
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  105     ISSN:  0340-6245     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-3-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Dr. Johann Wojta, PhD, Department of Internal Medicine II, Medical University of Vienna, A-1090 Vienna, Austria, Tel.: +43 1 40400 73500, Fax: +43 1 40400 73586, E-mail:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  ??-CAT, a non-lens betagamma-crystallin and trefoil factor complex, induces calcium-dependent platel...
Next Document:  D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulatio...